Cargando…
Predictors for Treatment Outcomes in Patients with Multi-drug Resistant Tuberculosis — China, 2018–2020
WHAT IS ALREADY KNOWN ABOUT THIS TOPIC? Multi-drug resistant tuberculosis (MDR-TB) is a critical global public health problem. WHAT IS ADDED BY THIS REPORT? Sputum cultures and lung images show a strong association with treatment outcomes, serving as a multi-dimensional approach to identify MDR-TB p...
Autores principales: | Zhang, Shunxian, Qiu, Lei, Wu, Dingzhong, Zhang, Shaoyan, Pan, Chenhui, Li, Cui, Xiao, Heping, Huang, Fuli, Wang, Hua, Jiang, Feng, Zhang, Huiyong, Zheng, Peiyong, Lu, Zhenhui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681604/ https://www.ncbi.nlm.nih.gov/pubmed/36426288 http://dx.doi.org/10.46234/ccdcw2022.187 |
Ejemplares similares
-
Epidemiological Data of Work-Related Musculoskeletal Disorders — China, 2018–2020
por: Jia, Ning, et al.
Publicado: (2021) -
Financial Burden of Tuberculosis Patients — China, 2020
por: Xu, Caihong, et al.
Publicado: (2023) -
Surveillance of Malaria Vectors — 18 Sites, 12 PLADs, China, 2018–2020
por: Li, Yuanyuan, et al.
Publicado: (2021) -
Age-Specific Pulmonary Tuberculosis Notification Rates — China, 2008–2018
por: Li, Tao, et al.
Publicado: (2022) -
Predicted Impact of the COVID-19 Responses on Deaths of Tuberculosis — China, 2020
por: Xu, Caihong, et al.
Publicado: (2021)